| Rank | Ticker | Country | Price | Market Cap | Avg Volume |
|---|---|---|---|---|---|
#1 | ACAD | US | $24.53 | $3.9B | $1.2M |
#2 | RELY | US | $17.18 | $3.0B | $3.1M |
#3 | BOF | US | $4.04 | $43.4M | $98.6K |
#4 | TPH | US | $46.33 | $2.8B | $2.3M |
#5 | INTS | US | $6.60 | $24.0M | $1.4M |
#6 | OMC | US | $80.62 | $24.2B | $4.2M |
#7 | OXY | N/A | $51.65 | $39.3B | $10.0M |
#8 | RCKT | N/A | $3.74 | $428.6M | $1.9M |
#9 | AURE | N/A | $2.05 | $86.5M | $473.5K |
#10 | CDNL | N/A | $32.33 | $980.9M | $115.8K |
#11 | KTTA | N/A | $0.81 | $16.2M | $131.8K |
#12 | CAPR | US | $28.71 | $1.3B | $957.8K |
#13 | TPL | US | $487.53 | $23.9B | $428.9K |
#14 | NDLS | US | $4.50 | $36.5M | $252.1K |
#15 | MASI | US | $175.27 | $7.0B | $1.5M |
The FinQuota filters have identified what they believe to be the "Hourly RSI Above 80: Very Overbought (20 February 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.